These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21864111

  • 21. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
    Tomimatsu T, Horie T.
    Chem Biol Interact; 2005 Aug 15; 155(3):129-39. PubMed ID: 15996645
    [Abstract] [Full Text] [Related]

  • 22. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP, Kanekal S, Patawaran MB, Chen JY, Jones RE, Orenberg EK, Yu NY.
    Cancer Chemother Pharmacol; 1999 Aug 15; 44(4):267-74. PubMed ID: 10447573
    [Abstract] [Full Text] [Related]

  • 23. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
    Lu JL, Wang JC, Zhao SX, Liu XY, Zhao H, Zhang X, Zhou SF, Zhang Q.
    Eur J Pharm Biopharm; 2008 Aug 15; 69(3):899-907. PubMed ID: 18434109
    [Abstract] [Full Text] [Related]

  • 24. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
    Lai LF, Guo HX.
    Int J Pharm; 2011 Feb 14; 404(1-2):317-23. PubMed ID: 21094232
    [Abstract] [Full Text] [Related]

  • 25. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH, Pazdur R, Covington W, Brown N, Huo YY, Lassere Y, Kuritani J.
    Clin Cancer Res; 1998 Sep 14; 4(9):2085-8. PubMed ID: 9748123
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC, Levy HV, Botner S.
    J Control Release; 2010 Dec 01; 148(2):168-76. PubMed ID: 20709120
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin.
    Xu M, Yu Q, Zhao Q, Chen W, Lin Y, Jin Y.
    Drug Dev Ind Pharm; 2016 Dec 01; 42(2):280-7. PubMed ID: 26165244
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
    Mishra BJ, Kaul A, Trivedi P.
    Drug Deliv; 2015 Feb 01; 22(2):214-22. PubMed ID: 24524408
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
    Ahmad MZ, Akhter S, Anwar M, Ahmad FJ.
    Mol Pharm; 2012 Nov 05; 9(11):2986-94. PubMed ID: 22994847
    [Abstract] [Full Text] [Related]

  • 37. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW, von Borstel R.
    Cancer Chemother Pharmacol; 2006 Jul 05; 58(1):136-42. PubMed ID: 16187114
    [Abstract] [Full Text] [Related]

  • 38. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
    Roullin VG, Lemaire L, Venier-Julienne MC, Faisant N, Franconi F, Benoit JP.
    Anticancer Res; 2003 Jul 05; 23(1A):21-5. PubMed ID: 12680190
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005).
    O'Donnell A, Punt CJ, Judson I, Van Maanen L, Suttle AB, Ertel P, Beale P.
    Cancer Chemother Pharmacol; 2003 Jan 05; 51(1):58-66. PubMed ID: 12497207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.